Amsterdam, the Netherlands—June 20, 2023—argenx SE (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, today ...

A simple blood test can tell which patients will develop devastating motor neurone disease a decade before symptoms appear, a groundbreaking study has revealed. Neurology experts at the Johns Hopkins ...

Results of a largescale collaborative project led by scientists at the Cedars-Sinai Medical Center, Los Angeles, and the University of California, Irvine (UCI), were published in the journal Neuron ...